Besides, a recent report revealed that AKT-mediated phosphorylation of the serine residues, located N-terminal to the DLC1 RhoGAP domain, greatly attenuated its RhoGAP and tumor-suppressor activities [45]. The gene discussed is AKT1; the disease is neoplasm.